# Plant Response Biotech

Plant Response Biotech is an Agricultural Biotechnology based in Raleigh, United States.

## Overview

- **Organization type:** Agricultural Biotechnology
- **Headquarters:** Raleigh, United States
- **Region:** North America
- **Address:** Raleigh, NC, United States
- **Founded:** 2008
- **Assets under management:** Undisclosed
- **Website:** https://www.plantresponse.com
- **LinkedIn:** https://www.linkedin.com/company/plantresponse-biotech

## Regulatory record

- **Reports private funds:** No

## About

Plant Response Biotech was founded in Raleigh, North Carolina, as a spinout from academic research focused on plant stress responses. The firm leverages proprietary libraries of natural molecules to create biostimulants and biopesticides, aiming to reduce reliance on synthetic agricultural chemicals. Its wealth origin is not publicly disclosed; the company is structured as a venture-capital-backed entity rather than a family office. The firm's strategy centers on developing and commercializing biological products that improve crop yield under stress conditions such as drought, salinity, and pest pressure. Its pipeline spans seed treatments, foliar sprays, and soil amendments across multiple crop platforms, including corn, soybeans, and wheat. Plant Response Biotech partners with agricultural input distributors and contract research organizations for field trials and regulatory approvals. The firm has disclosed a product development pipeline with at least three lead candidates in greenhouse-to-field stage, though no named portfolio companies or co-investors are publicly listed. Geographic operations are concentrated in the United States, with potential expansion into Latin American growing regions where abiotic stress is a persistent challenge. The firm's team size and professional roster are not publicly documented. No dated operational event from the last 24 months is verifiable in public records; the firm maintains a low profile with limited press coverage. A structural differentiator is the firm's focus on natural compounds rather than synthetic chemistry or genetic modification, positioning it within the biologicals segment of the agricultural input industry. This mandate distinguishes it from conventional ag-biotech firms that rely on transgenic approaches. The firm's governance and succession structure are not publicly known.

## Sectors

- AgriTech & FoodTech
- ClimateTech
- Biotech

## Questions

### How does Plant Response Biotech source proprietary deal flow?

The firm operates as an asset manager developing its own intellectual property from in-house discovery platforms rather than acquiring external technologies. Its research is built on proprietary libraries of natural molecules, giving it an internal pipeline that does not rely on external licensing or M&A for deal flow.

### What investment stages does Plant Response Biotech typically target?

The firm targets early-stage product development through to commercialization. Its activities span research and development (R&D) for lead candidates, greenhouse and field trials, and regulatory approval processes. It does not invest in external companies at any stage.

### What is Plant Response Biotech's known posture on co-investments alongside external GPs?

There is no public information regarding co-investments. The firm is not structured as an investment vehicle and does not appear to co-invest alongside external general partners.

## Related profiles

- [GlideFast Consulting](https://altss.com/profile/glidefast-consulting-llc)
- [Bright Health Management](https://altss.com/profile/bright-health-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/plant-response-biotech

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology